News

Echinocandins as alternative treatment for Pneumocystis in HIV-infected patients?

In a Taiwanese study, 34 HIV-positive patients with Pneumocystis Pneumonia (PCP) who were intolerant (25/34) or who were unresponsive (9/34) to trimethoprim-sulfamethoxazole (TMP-SMX) were treated with echinocandins alone or in combination with other agents. Read more

Benefit of early HIV-therapy on CD4 count

The START-study is a landmark study of immediate therapy versus delayed treatment initiation (less than 350 cells/μL) in HIV-positive patients with more than 500 CD cells/μL at randomization. Read more

Magazine